Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

Hasford, Joerg; Baccarani, Michele; Hoffmann, Verena; Guilhot, Joëlle; Saußele, Susanne; Rosti, Gianantonio; Guilhot, François; Porkka, Kimmo; J. Ossenkoppele, Gert; Lindoerfer, Doris; Simonsson, Bengt; Pfirrmann, Markus; Hehlmann, Rüdiger

doi:10.1182/blood-2010-12-319038

Public

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

Published in Blood • May 3, 2011

Authors:

Joerg Hasford

Michele Baccarani

Verena Hoffmann

Abstract

The outcome of chronic myeloid leukemia (CML) has been profoundly changed by the introduction of tyrosine kinase inhibitors into therapy, but the prognosis of patients with CML is still evaluated using prognostic scores developed in the chemotherapy and interferon era. The present work describes a n...

Subject

Medicine

Imatinib

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!